Small increases in serum magnesium levels by dapagliflozin and normalisation of hypomagnesaemia in patients with type 2 diabetes

被引：0
|
作者：
Toto, R. [1 ]
Goldenberg, R. [2 ]
Chertow, G. M. [3 ]
Cain, V. [4 ]
Stefansson, B. V. [5 ]
Sjostrom, C. D. [5 ]
Sartipy, P. [5 ]
机构：
[1] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA
[2] LMC Diabet & Endocrinol, Thornhill, ON, Canada
[3] Stanford Sch Med, Stanford, CA USA
[4] Bogier Clin & IT Solut, Raleigh, NC USA
[5] AstraZeneca, Cardiovasc Renal & Metab Dis, Gothenburg, Sweden
来源：
DIABETOLOGIA | 2018年 / 61卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
651
引用
收藏
页码：S316 / S316
页数：1
相关论文
共 50 条
  • [1] Serum Magnesium Levels in Type 2 Diabetes Mellitus
    Parlapally, Rajendra Prasad
    Kumari, Katakam Rajini
    Jyothi, Somasila Aruna
    [J]. INTERNATIONAL JOURNAL OF SCIENTIFIC STUDY, 2016, 4 (05) : 176 - 179
  • [2] DAPAGLIFLOZIN MODULATES ADROPIN SERUM LEVELS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND CHRONIC HEART FAILURE
    Berezin, Alexander
    Fushtey, Ivan M.
    Berezin, Alexander A.
    [J]. JOURNAL OF HYPERTENSION, 2023, 41 : E100 - E100
  • [3] Study of Serum Magnesium Levels in Type 2 Diabetes Mellitus
    Khanna, Deepanshu
    Bhatnagar, Mini
    Tayal, Shankar
    [J]. JOURNAL OF EVOLUTION OF MEDICAL AND DENTAL SCIENCES-JEMDS, 2020, 9 (04): : 206 - 210
  • [4] Serum Magnesium Levels in Type 2 Diabetes Patients and its Relation with Diabetic Nephropathy
    Kumar, C. Anjani
    Kolli, Sumanas Gopal Datta
    Katta, Seetha
    Katta, Shubha
    [J]. INTERNATIONAL JOURNAL OF MEDICAL RESEARCH & HEALTH SCIENCES, 2018, 7 (07): : 90 - 94
  • [5] Acarbose treatment increases serum total adiponectin levels in patients with type 2 diabetes
    Ochiai, Hiromi
    Ooka, Hikari
    Shida, Chiho
    Ishikawa, Toshio
    Inoue, Daisuke
    Okazaki, Ryo
    [J]. ENDOCRINE JOURNAL, 2008, 55 (03) : 549 - 556
  • [6] Dapagliflozin, a selective SGLT2 inhibitor, reduces serum levels of uric acid in patients with type 2 diabetes
    Hardy, E.
    Rohwedder, K.
    Hrub, V.
    Salsali, A.
    Ying, L.
    Sugg, J.
    List, J. F.
    Parikh, S.
    [J]. DIABETOLOGIA, 2011, 54 : S344 - S345
  • [7] Effects of dapagliflozin on serum and urinary uric acid levels in patients with type 2 diabetes: a prospective pilot trial
    Tao Yuan
    Shixuan Liu
    Yingyue Dong
    Yong Fu
    Yan Tang
    Weigang Zhao
    [J]. Diabetology & Metabolic Syndrome, 12
  • [8] Effects of dapagliflozin on serum and urinary uric acid levels in patients with type 2 diabetes: a prospective pilot trial
    Yuan, Tao
    Liu, Shixuan
    Dong, Yingyue
    Fu, Yong
    Tang, Yan
    Zhao, Weigang
    [J]. DIABETOLOGY & METABOLIC SYNDROME, 2020, 12 (01):
  • [9] Dapagliflozin, as Add-on Therapy in Type 2 Diabetes Patients, Is Associated With a Reduction in Albuminuria and Serum Transaminase Levels
    Benjamin, Silas
    Ramanjaneya, Manjunath
    Butler, Alexandra E.
    Janjua, Imran
    Paramba, Firjeeth
    Palaki, Jafer
    Al Kubaisi, Aisha
    Chandra, Prem
    Abdalhakam, Ibrahem
    Massodi, Nasseer Ahmad
    [J]. FRONTIERS IN CLINICAL DIABETES AND HEALTHCARE, 2021, 2
  • [10] Effect of dapagliflozin on proteomics and metabolomics of serum from patients with type 2 diabetes
    Liu, Jia
    Chang, Xiaona
    Ding, Xiaoyu
    He, Xueqing
    Wang, Jiaxuan
    Wang, Guang
    [J]. DIABETOLOGY & METABOLIC SYNDROME, 2023, 15 (01):
12345